Meda AB (publ) AGM bulletin

At the annual general meeting (AGM) on May 4, 2011, of Meda AB (publ), corporate ID 556427-2812, Box 906, SE-170 09 Solna, Sweden, declared a dividend of SEK 2.00 (two kronor) per share .

The AGM adopted balance sheets and income statements and discharged the members of the board and the CEO from liability for the fiscal year 2010.

The board was elected as proposed by the nomination committee. The nomination committee’s proposal for remuneration to the board and the auditors was adopted.

The AGM authorized the board to make decisions on the issue of shares and convertibles, and on buying and selling Meda shares. The AGM also resolved to amend 9§ p.10 in the articles of association.

Details of the AGM resolutions are available at Meda’s head office at Pipers väg 2A, Solna, Sweden, or by calling +46 8-630 1900. They will be sent on request free of charge to shareholders who provide an address.

The board

For further inquiries, please contact:

Anders Larnholt, Vice President Corporate Development & IR ph: 46 709-458 878

MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in 120 countries worldwide and the company is represented by its own organizations in 50 countries. The Meda share is listed under Large Cap on the Nasdaq OMX Nordic Stock Exchange in Stockholm. Find out more, visit www.meda.se.